SI-BONE, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $200.9M | $167.2M | $138.9M | $106.4M | $90.2M |
| Cost of revenue | $41.0M | $35.1M | $29.5M | $15.7M | $10.4M |
| Gross profit | $159.9M | $132.1M | $109.4M | $90.7M | $79.7M |
| Research and development | $17.4M | $16.6M | $15.0M | $13.6M | $12.4M |
| Operating expenses | $182.2M | $167.4M | $156.4M | $150.3M | $131.4M |
| Operating income | -$22.3M | -$35.2M | -$46.9M | -$59.6M | -$51.7M |
| Interest expense | $2.6M | $3.4M | $3.5M | $2.8M | $5.4M |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$18.9M | -$30.9M | -$43.3M | -$61.3M | -$56.6M |
| Balance Sheet | |||||
| Cash and equivalents | $42.2M | $34.9M | $33.3M | $20.7M | $63.4M |
| Current assets | $216.1M | $207.8M | $211.4M | $137.6M | $175.9M |
| Total assets | $238.6M | $230.4M | $230.4M | $157.6M | $190.5M |
| Current liabilities | $25.3M | $27.1M | $23.5M | $21.2M | $16.9M |
| Total liabilities | $61.0M | $63.5M | $61.0M | $59.2M | $56.1M |
| Total debt | $36.0M | $36.0M | $36.0M | $35.7M | $35.7M |
| Stockholders' equity | $177.5M | $167.0M | $169.4M | $98.3M | $134.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$675,000 | -$12.4M | -$18.7M | -$41.7M | -$39.5M |
| Depreciation and amortization | $5.8M | $4.4M | $5.4M | $3.5M | $2.1M |
| Stock-based compensation | $25.5M | $25.9M | $24.1M | $23.1M | $16.9M |
| Capital expenditure | $8.4M | $10.5M | $7.8M | $9.5M | $6.4M |
| Free cash flow | -$9.1M | -$22.9M | -$26.5M | -$51.2M | -$45.9M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 44.3M · Free float 86.5%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.